Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epithelial immune activation and intracellular invasion by non-typeable Haemophilus influenzae. | Front Cell Infect Microbiol | 2023 | 37180449 | PubTator, text mining | PubMed |
| Blood-feeding adaptations and virome assessment of the poultry red mite Dermanyssus gallinae guided by RNA-seq. | Commun Biol | 2023 | 37179447 | PubTator, text mining | PubMed |
| The role and metabolic adaptations of neutrophils in premetastatic niches. | Biomark Res | 2023 | 37158964 | PubTator, text mining | PubMed |
| A single-cell view on host immune transcriptional response to in vivo BCG-induced trained immunity. | Cell Rep | 2023 | 37155329 | PubTator, text mining | PubMed |
| Pre-metastatic niche: from revealing the molecular and cellular mechanisms to the clinical applications in breast cancer metastasis. | Theranostics | 2023 | 37153744 | PubTator, text mining | PubMed |
| Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis. | ERJ Open Res | 2023 | 37143828 | PubTator, text mining | PubMed |
| Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases. | Mol Neurodegener | 2023 | 37131250 | PubTator, text mining | PubMed |
| Mechanisms of cancer-associated thrombosis. | Res Pract Thromb Haemost | 2023 | 37122533 | PubTator, text mining | PubMed |
| Advances in Drug Discovery Targeting Lysosomal Membrane Proteins. | Pharmaceuticals (Basel) | 2023 | 37111358 | PubTator, text mining | PubMed |
| Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37108335 | PubTator, text mining | PubMed |
| Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma. | Biosci Rep | 2023 | 37103469 | PubTator, text mining | PubMed |
| A novel integrated approach to predicting cancer immunotherapy efficacy. | Oncogene | 2023 | 37100920 | PubTator, text mining | PubMed |
| Dipeptide analogues of fluorinated aminophosphonic acid sodium salts as moderate competitive inhibitors of cathepsin C. | Beilstein J Org Chem | 2023 | 37091732 | PubTator, text mining | PubMed |
| Transcriptomics unravels molecular changes associated with cilia and COVID-19 in chronic rhinosinusitis with nasal polyps. | Sci Rep | 2023 | 37085563 | PubTator, text mining | PubMed |
| Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation. | BMC Res Notes | 2023 | 37069668 | PubTator, text mining | PubMed |
| Lysosomal chloride transporter CLH-6 protects lysosome membrane integrity via cathepsin activation. | J Cell Biol | 2023 | 37058288 | PubTator, text mining | PubMed |
| ATG5 provides host protection acting as a switch in the atg8ylation cascade between autophagy and secretion. | Dev Cell | 2023 | 37054706 | PubTator, text mining | PubMed |
| A Multiple Targeting Nanoprobe for Identifying Cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells. | Nano Lett | 2023 | 37052638 | PubTator, text mining | PubMed |
| The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients. | Cells | 2023 | 37048076 | PubTator, text mining | PubMed |
| Exploring the potential targets of the Abrus cantoniensis Hance in the treatment of hepatitis E based on network pharmacology. | Front Vet Sci | 2023 | 37035802 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=18